Nominations Open for 2008 Landon-AACR Prizes
July 10, 2007
PHILADELPHIA - The American Association for Cancer Research is pleased to invite nominations for the seventh annual Landon-AACR Prizes for Basic and Translational Cancer Research. Nominations will be open until August 24, 2007.
These two major international prizes recognize seminal basic and translational cancer research discoveries at the cutting edge of scientific novelty and significance. Eligible candidates are active, recently published scientists who have made extraordinary advances in cancer research, and whose scientific innovation and creativity have accelerated progress against cancer and have implications for future discoveries and contributions to cancer research.
Past winners of the Kirk A. Landon-AACR Prize for Basic Cancer Research:
2007: Richard D. Kolodner, Ph.D.
University of California, San Diego
2006: Robert A. Weinberg, Ph.D.
Whitehead Institute for Biomedical Research, Cambridge, Mass.
2005: Elizabeth H. Blackburn, Ph.D.
University of California, San Francisco
2004: Tony Hunter, Ph.D.
The Salk Institute for Biological Studies, La Jolla, Calif.
2003: Charles J. Sherr, M.D., Ph.D.
St. Jude Children's Research Hospital, Memphis, Tenn.
2002: Robert N. Eisenman, Ph.D.
Fred Hutchinson Cancer Research Center, Seattle, Wash.
Past winners of the Dorothy P. Landon-AACR Prize for Translational Cancer Research:
2007: Douglas R. Lowy, M.D. & John T. Schiller, Ph.D.
National Cancer Institute, Bethesda, Md.
2006: Angela M. Hartley Brodie, Ph.D.
University of Maryland School of Medicine, Baltimore
2005: Janet D. Rowley, M.D.
University of Chicago Medical Center, Chicago, Ill.
2004: Raymond N. DuBois, M.D., Ph.D.
Vanderbilt-Ingram Cancer Center, Nashville, Tenn.
2003: Dennis J. Slamon, M.D., Ph.D.
University of California, Los Angeles Jonsson Cancer Center
2002: Elwood V. Jensen, Ph.D.
University of Cincinnati, Cincinnati, Ohio
V. Craig Jordan, Ph.D.
Fox Chase Cancer Center, Philadelphia, Pa.
The recipient of each prize will receive an unrestricted cash award of $100,000. Both will present lectures during the AACR Annual Meeting, April 12-16, 2008, in San Diego, Calif., to stimulate and inspire their colleagues to new thinking and fresh approaches in both basic and translational cancer research. They will also participate in the annual Landon-AACR Prize Symposium at the University of Miami/Sylvester Comprehensive Cancer Center in January 2009.
For further information on the nomination process and other details about the prizes, please click here. Inquiries regarding this award should be directed to Monique Eversley at firstname.lastname@example.org.
# # # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes nearly 26,000 basic, translational, and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 70 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts over 17,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment, and patient care. AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. Its most recent publication, CR, is a magazine for cancer survivors, patient advocates, their families, physicians, and scientists. It provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship, and advocacy.
The Kirk A. and Dorothy P. Landon Foundation was created through a bequest from Mrs. Dorothy P. Landon whose intent, along with that of her late husband, Kirk A. Landon, was to dedicate a major portion of their estate to medical research, especially research related to cancer. Mr. R. Kirk Landon, son of Kirk A. Landon, serves as the President of the Foundation. The Foundation seeks to accomplish its cancer research mission through a variety of programs and initiatives, the most important of which are the Landon-AACR Prizes.